Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05545930

Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)

The purpose of this research study is to compare two methods of recovering blood from surgical sponges used during heart and lung surgeries. The two methods are: 1) manually wringing sponges by hand, and 2) automated wringing sponges by an FDA approved suction device. Both methods are already in use in heart and lung surgeries at University Hospitals at the discretion of the surgeon.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–89 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospitals Cleveland Medical Center

Cleveland, Ohio, 44106, United States

Location status: Recruiting

Location contact

Craig Jarrett, MD, MBA

CONTACT

[email protected]

216-286-7297

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Undergoing heart or lung transplant, redo sternotomy, aortic surgery, and/or multi-valve repairs/replacements; and
  • At University Hospitals Cleveland Medical Center.

Exclusion criteria

  • Patients with known bleeding disorders, including disseminated intravascular coagulation (DIC), prothrombin deficiency, factor V deficiency, factor VII deficiency, factor X deficiency, factor XI deficiency (hemophilia C), Glanzmann disease, hemophilia A, hemophilia B, idiopathic thrombocytopenic purpura (ITP), and Von Willebrand disease (types I, II, and III);
  • Patients undergoing emergent or emergent salvage surgery; and
  • Patients actively participating in another clinical trial which could affect outcomes.

Treatment and study plan

Hand Wrung

Procedure

Hand wrung refers to manually wringing surgical sponges by hand.

ProCell Wrung

Device

ProCell wrung refers to automated wringing surgical sponges by an FDA approved suction device (ProCell).

Primary outcomes

  1. Level of Plasma Free Hemoglobin

    Time frame: Baseline

    Level of plasma free hemoglobin will be measured at baseline.

  2. Level of Plasma Free Hemoglobin

    Time frame: Post-Processing (Up to 120 Minutes)

    Level of plasma free hemoglobin will be measured post-processing.

  3. Change in Volume of Blood

    Time frame: Baseline, Post-Processing (Up to 120 Minutes)

    Volume of blood will be measured at baseline and post-processing.

Secondary outcomes

  1. Number of Fragmented Red Blood Cells

    Time frame: Baseline

    Number of fragmented red blood cells will be measured at baseline.

  2. Number of Fragmented Red Blood Cells

    Time frame: Post-Processing (Up to 120 Minutes)

    Number of fragmented red blood cells will be measured post-processing.

  3. Level of Lactate Dehydrogenase

    Time frame: Baseline

    Level of lactate dehydrogenase will be measured at baseline.

  4. Level of Lactate Dehydrogenase

    Time frame: Post-Processing (Up to 120 Minutes)

    Level of lactate dehydrogenase will be measured post-processing.

  5. Level of Haptoglobin

    Time frame: Baseline

    Level of haptoglobin will be measured at baseline.

  6. Level of Haptoglobin

    Time frame: Post-Processing (Up to 120 Minutes)

    Level of haptoglobin will be measured post-processing.

  7. Change in Weight of Surgical Sponge

    Time frame: Baseline, Post-Procedure (Up to 5 Minutes)

    Weight of surgical sponges will be measured at baseline and post-procedure.

  8. Time to Wring Sponges

    Time frame: Up to 120 Minutes

    Time to wring sponges will be measured.

Study contacts

Contact information is provided by the study sponsor or research team.

Jessica Hungate, MD

CONTACT

[email protected]

216-844-3800

Sponsors and collaborators

Lead sponsor

University Hospitals Cleveland Medical Center

Other

Collaborators

  • ProCell Surgical Inc.

Registry information

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Sep 19, 2022
Registry last updated
Jan 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.